Join us in Episode 374 of The Low Mein's Asylum Show as we delve into the complex interplay between technology and society. In this thought-provoking episode, we explore two pressing topics: "The Ethics of AI in Healthcare" and "Social Media's Influence on Mental Health."

First, we unravel the ethical considerations surrounding the integration of AI in healthcare, examining its potential benefits and the challenges it poses to patient privacy and equitable healthcare delivery. Then, we shift our focus to the pervasive influence of social media on mental health, dissecting its impact on self-perception, relationships, and overall well-being.

Featuring insightful interviews with experts in healthcare ethics and mental health, this episode offers a deep dive into the ethical dilemmas and societal implications of technological advancements. Tune in as we navigate the murky waters where innovation meets responsibility, and discover how we can shape a more ethical and empathetic future in the digital age.

Don't miss Episode 374 of The Low Mein's Asylum Show, where curiosity meets conversation and insights abound.

Bytes Of Consequence- Navigating Tech's Impact On Society

Synopsis:
 
Rob Williamson, CEO of Triumvira, joins Biotech 2050 host, Rahul Chaturvedi, to discuss his dynamic career from economics to biotech, tackling the volatile capital markets, and navigating high-stakes decisions in cell therapy. He shares insights on therapeutic developments in cell therapy, the pressures of solid tumor research, and the evolving biotech ecosystem. A deep dive into biotech board dynamics, funding strategies, and the potential of AI in healthcare, Rob offers invaluable lessons and forward-thinking perspectives on life sciences and patient care innovation.

Biography:

Robert F. Williamson, III has been active in building biotechnology companies and shareholder value for over two decades. He currently is the President and COO of Triumvira Immunologics. Previously, he was the CBO of OncoMyx, an oncolytic virus company, and CEO of BioTheryX, a protein degradation therapeutics company, raising a $100M crossover round and preparing the company for an IPO. Prior to BioTheryX, Mr. Williamson served as CEO of both PharmAkea and ATXCo, oncology and fibrosis companies financed through a partnership with Celgene, until PharmAkea’s acquisition by Galecto and ATXCo’s acquisition by Blade Therapeutics. Prior, Mr. Williamson was CEO of Arriva Pharmaceuticals, President and COO of Eos Biotechnology, which he sold to Protein Design Labs, and COO of DoubleTwist, Inc. through its acquisition by Merck and Hitachi.

Mr. Williamson also serves as a director and adviser for foundations, private, and public companies. Notably, Mr. Williamson served as an early Director of Pharmasset, Inc., where he helped finance, grow, and advance the company into the public markets and through its acquisition by Gilead in 2011 for $11 billion. Earlier, Mr. Williamson was a Partner with The Boston Consulting Group and a Research Assistant for the Federal Reserve Board. He received a BA in economics from Pomona College and an MBA from Stanford.

Rob Williamson, CEO of Triumvira, on Biotech’s High-Stakes Path and Cell Therapy Innovations

🔥 Welcome to the Weekly AI News Roundup with Shaily! Hosted by Shailendra Kumar (Shaily), this episode dives into the most exciting Artificial Intelligence and Machine Learning updates for the week starting March 23, 2025. From China’s DeepSeek launching its powerful multi-modal AI model to Samsung introducing the Gauss AI for smarter consumer tech, we spotlight deep learning breakthroughs and the latest machine learning developments shaping our future.

Discover how Insilico Medicine’s AI-developed drug Rentosertib marks a huge win for healthcare innovation, and why Shield AI’s $240M funding signals the rise of advanced autonomous AI systems. Whether you’re a researcher, developer, or business leader, these updates reveal how AI is disrupting industries and unlocking new possibilities worldwide.

Shaily unpacks why multi-modal AI is the frontier to watch, shares tips for integrating AI across data types, and offers unique insights into regulatory, healthcare, and consumer trends. 🤖💡

Don’t miss out—subscribe for more weekly AI news, like this episode, and join the conversation on YouTube, Twitter, LinkedIn, or Medium. Stay informed, stay curious, and be part of the AI revolution! 🚀

DeepSeek’s Big Leap: AI News with Shaily for Week starting June 2

In this episode, Patrick Mobley, Co-Founder and CEO at Vivid Health shares how his personal background and professional journey inspired him to launch a platform that improves clinical workflows using generative AI.

Built in collaboration with Redesign Health, Vivid Health’s platform is designed to automate time-consuming, manual processes, such as patient outreach, assessments, care planning, and follow-ups—freeing nurses and care teams to focus on providing care. Patrick highlights their “provider-led AI” approach, where providers retain final control over AI-generated outputs. The platform supports over 100 conditions across 16 specialties and is being adopted in primary care, home health, and hospice settings. It reduces documentation time by over 50% and eliminates outreach labor in chronic care management workflows.

Patrick also emphasizes the platform’s value in scaling care, improving patient engagement, and supporting revenue generation, while offering deeper, more honest insights through automated, holistic patient assessments. Take a listen.

We Believe in Provider-led AI Where Clinicians Have the Final Say - Podcast with Patrick Mobley

🎙️ Welcome to Weekly AI News with Shaily! 🚀 In this week’s AI news roundup (week starting June 6, 2025), we unpack the latest machine learning developments, deep learning breakthroughs, and game-changing industry moves in artificial intelligence. 

First, we spotlight healthcare AI: researchers Pavel Dolin and Fardis Nadimi unveil new frameworks focused on trust and privacy—including a robust monitoring system for clinical AI and SHIFT, a privacy-preserving, federated learning framework for augmented reality in healthcare. Why does this matter? Reliable and private AI is vital for patient safety and adoption, giving researchers and hospitals more confidence in next-gen tech. 🩺🔒

Next up, Eleven Labs drops Eleven v3—an expressive AI speech model bringing more human, emotional voices to businesses and developers. 📢 Meanwhile, Google’s Gemini 2.5 Pro sets new AI benchmarks, promising smarter coding assistants, content generators, and more. Databricks and Snowflake make billion-dollar moves, showing quality data infrastructure is the backbone of any successful AI project. 📈

Finally, Filament Games launches AI tools for education, putting AI literacy and creativity in students’ hands. 

Hosted by Shailendra Kumar (Shaily), this podcast helps researchers, developers, and business leaders stay ahead. Subscribe, follow, and share to keep exploring the ever-evolving world of AI! 🌟

Is Healthcare AI Finally Trustworthy? | News with Shaily for Week starting 2025-06-09

In this episode, Dr. T.Y. Alvin Liu, Inaugural Director, James P Gills Jr MD and Heather Gills AI Innovation Center at Johns Hopkins Medicine shares his journey in healthcare AI, with a focus on image analysis and real-world applications.
Dr. Liu discusses the FDA-approved autonomous AI system for diabetic retinopathy screening, which enables early detection in primary care settings and improves screening adherence. He outlines successful AI implementations at Johns Hopkins, including prior authorization pilots using generative AI and the importance of operational understanding in deployment. He also discussed the intersection of value-based medicine and artificial intelligence, and the challenges of implementing successful AI programs. 
At the enterprise level, Dr. Liu emphasizes the need for strong AI governance to assess safety, effectiveness, and ROI. He outlines key challenges for AI startups, especially around reimbursement and regulation, and urges them to pursue sustainable business models. He also suggests closer collaboration among startups, VCs, and integrated health systems to bridge the gap between innovation and real-world adoption, essential for scaling AI responsibly and delivering long-term value in healthcare. Take a listen. 


Scaling With Autonomous AI for Diabetic Retinopathy Screening - Podcast with Alvin Liu

In this episode, Siva Namasivayam, Chief Executive Officer of Cohere Health, discusses the challenges and opportunities in overhauling the prior authorization process in healthcare. 

He shares how AI is being applied to reduce administrative delays, including the use of generative AI to summarize clinical data and intelligent agents to assist with scheduling and information retrieval processes. The conversation also touches on enabling real-time approvals for a majority of cases, designing algorithms informed by physician input, and navigating the shift to remote work. The discussion offers insight into how technology can address systemic inefficiencies while maintaining clinical oversight. Take a listen.

Transforming Prior Authorization with AI - Podcast with Siva Namasivayam

In this episode, Rob Posner, Chief Technology Officer, AbsoluteCare discusses how the organization is transforming care delivery through a member-centric, value-based model that emphasizes advanced care management and the social determinants of health.

Rob explains AbsoluteCare’s proactive, longitudinal care management approach – enabled by technology that empowers mobile care teams to engage with members wherever they are, whether at home, in the community, or within hospital settings. He underscores the importance of real-time data access, EMR availability at the point of care, and the role of transitional care managers in ensuring continuity post-discharge. Rob also emphasizes how governance, change management, and attention to operational details such as connectivity, mobility, and privacy are critical to success.

Rob also explores AbsoluteCare’s innovation strategy, including the use of ambient clinical documentation, AI-driven diabetic retinopathy screening, and organization-wide adoption of Microsoft Copilot. Rob shares his vision for the future of AI agents and robotic process automation to streamline workflows, reduce provider burden, and ultimately improve care outcomes. Take a listen

When Technology Meets Care Management, Outcomes Improve. - Podcast with Rob Posner

In this episode, Aneesh Chopra, Chief Strategy Officer at Arcadia shares a bold vision for advancing healthcare equity through smarter data use, AI, and workflow innovation. He unpacks the journey from the early days of “meaningful use” to today’s AI-powered, value-based care landscape, highlighting how intelligent workflows can reach underserved populations and improve outcomes at scale.

Aneesh introduces the concept of a “healthcare information fiduciary,” a model where apps and platforms act solely in the patient’s best interest, free from institutional financial incentives. He discusses how this, combined with emerging AI capabilities and interoperability standards like CMS’s FHIR APIs, can empower consumers and scale high-impact care delivery.

With real-world success stories, from improved hospital ratings via conversational AI to national gains in ADT data coverage, this episode offers healthcare leaders a roadmap for driving innovation through public-private collaboration and patient-centered data strategy. Take a listen.

Reimagining Healthcare From Meaningful Use of Data to AI-Driven Equity - Podcast with Aneesh Chopra

In this episode, Dr. Vishisht Mehta, Director of Interventional Pulmonology, Comprehensive Cancer Centers of Nevada and also the Department Chair of Pulmonology at MountainView Hospital, discusses his passion for clinical practice and emerging technologies like AI and telemedicine. 

He shares how his interest in AI began through vendor outreach and evolved into a deeper exploration of its applications in pulmonology, particularly in early lung cancer detection and functional imaging. Dr. Mehta highlights the persistent underutilization of lung cancer screenings, with only 5–6% of eligible patients getting screened, and notes AI’s role in identifying high-risk individuals and managing lung nodules. He also emphasizes the value of telemedicine in improving patient access and outcomes. 

Dr. Mehta has also created a resource hub – https://pulmonary.ai/ – and produced educational videos to guide clinicians in understanding and adopting AI tools. He advises that physicians must gain foundational AI literacy to make informed technology decisions in an increasingly digital healthcare landscape. Take a listen.

Vishisht Mehta MD, Director, Interventional Pulmonology Comprehensive Cancer Centers of Nevada

In this episode, Sara Vaezy, Chief Transformation Officer at Providence, discusses Providence’s strategic approach to digital transformation, consumer engagement, and responsible AI adoption to improve both patient and caregiver experiences.

Sara highlights the importance of delivering personalized, frictionless, and proactive healthcare experiences across digital touchpoints. At Providence, a standout initiative is the use of conversational AI to enable ‘message deflection’ which reduces the volume of patient messages sent to physicians by helping patients resolve queries instantly through intelligent chatbots. Sara emphasizes building a digital workforce not just to automate routine tasks, but to rethink and redesign workflows creatively. With foundational investments in cloud infrastructure, unified data systems, and interoperability, Providence is well-positioned to scale AI use cases like ambient documentation and care navigation. 

Sara also shares how Providence has incubated and spun off innovative startups like DexCare and Praia Health to address critical gaps in supply-demand matching and patient personalization. She advocates for ethical AI governance, better observability tools, and designing AI-native healthcare processes that go beyond simply replacing human tasks. Take a listen.


Sara Vaezy, Chief Transformation Officer, Providence

In this episode, Alicia Abella, AI Product Lead at Novo Nordisk, discusses how she is helping drive responsible AI adoption in the pharmaceutical industry. She shares her early experiences in AI, starting with her PhD research at Columbia University on image processing and natural language processing.

At Novo Nordisk, the current focus is on applying AI to commercialization functions including - marketing, legal, and HR - beyond its traditional use in drug discovery. Alicia highlights key use cases such as generative AI for knowledge search, content generation for marketing campaigns, and traditional AI techniques for deriving insights about healthcare providers. She also emphasizes the importance of applying a product mindset to AI development by evaluating user needs, business value, and compliance from the outset.

Alicia notes that adding effective governance can help innovation move in the right direction. She also talks about an internal AI Ambassador Program and emphasizes the importance of designing intuitive AI tools to increase adoption. She concludes by discussing future trends in AI, including contextual intelligence, user-centric design, and the opportunity for AI to enhance, rather than replace human decision-making. Take a listen.


Alicia Abella, AI Product Lead, Novo Nordisk

In this episode, Michael Marchant, Director of Digital Applications at Sutter Health, shares his expert perspective on how interoperability and AI are reshaping the future of healthcare. He discusses the promise of TEFCA (Trusted Exchange Framework and Common Agreement) in expanding data exchange beyond treatment to support broader care coordination. He also highlights California’s Data Exchange Framework as a model for equitable and inclusive health information sharing across diverse communities.

The conversation explores the real-world applications of generative AI in clinical settings, from ambient documentation to AI-powered inbox agents that reduce administrative burden and help clinicians deliver faster, more personalized care.

Michael emphasizes the importance of assistive, not autonomous, AI, spotlighting use cases where technology enhances the capabilities of care teams without replacing the human touch. Drawing on decades of experience in health IT and data policy, Michael offers a grounded yet visionary take on building scalable, interoperable, and patient-centered digital ecosystems. Take a listen.

Michael Marchant, Director of Digital Applications, Sutter Health

Explore regulatory‑grade multimodal data de‑identification and tokenisation with Youssef Mellah, PhD, Senior Data Scientist at John Snow Labs and Srikanth Kumar Rana, Solutions Architect at Databricks. 
Learn how to remove, mask or transform PHI across clinical notes, tables, PDFs and DICOMs at scale, while meeting HIPAA, GDPR and CCPA standards — all without sacrificing analytical value. 

Timestamps
00:00 – Welcome & Episode Overview
02:43 – How Databricks supports secure De‑identification workflows
03:50 – Built-in techniques: masking, encryption, hashing
05:26 – Introduction to Multimodal Data De-Identification
07:15 – OCR + NLP pipeline for visual & text data – PHI Extraction
08:35 – Notebook demo: PHI identification in clinical notes
12:00 – PDF de-identification
12:56 – DICOM file de-identification
14:18 – Output: consistent masking across all modalities

Listen on:
• ⁠⁠Apple Podcast⁠⁠: https://podcasts.apple.com/us/podcast/the-healthcare-ai-podcast/id1827098175
• ⁠⁠Spotify⁠⁠: https://open.spotify.com/show/2XNrQBeCY7OGql2jVhcP7t 
• Amazon Music⁠⁠: https://music.amazon.com/podcasts


Connect with us:

Our website: https://www.johnsnowlabs.com/
LinkedIn: https://www.linkedin.com/company/johnsnowlabs/
Facebook: https://www.facebook.com/JohnSnowLabsInc/
X: https://x.com/JohnSnowLabs

The Healthcare AI Podcast – Ep. 2: De-Identification in Multimodal Medical Data (Text, PDF, DICOM)

In this episode, Ashis Barad, Chief Digital Technology Officer at the Hospital for Special Surgery (HSS), discusses his journey in rehumanizing healthcare through digital health transformation. A practicing pediatric gastroenterologist, Ashis advocates for tech that genuinely solves problems, viewing himself as a “doctor first, technologist second.”

Ashis stresses on Agentic AI and change management as pivotal elements in healthcare transformation. Healthcare is inherently workflow-centric, not a series of isolated moments. Barad explains Agentic AI as a workflow orchestrator designed to reduce administrative waste, enhance patient experience, and accelerate the adoption of best practices.

Ashis outlines HSS’s strategy to leverage its specialized focus to build a modern data lakehouse architecture and deploy AI-powered solutions through key partnerships. He envisions rehumanizing healthcare by automating backend processes, expanding clinician-patient time, and codifying best practices that can be scaled globally, especially in musculoskeletal care and movement. Take a listen.

Dr. Ashis Barad, Chief Digital Technology Officer, Hospital for Special Surgery (HSS)

Unlock the secrets of data mastery with Shailendra, a 27-year veteran in AI, ML, and Data Science, driving AU$ 6 Billion in transformative value. As the author of 'Making Money out of Data,' their strategies redefine digital success. With expertise honed at IBM and Accenture, they drive innovation and data monetization. Explore how loyalty programs like Flybuys and Everyday Rewards revolutionize business—connect with Shaily today.

Explore real-world applications of generative AI, large language models, and advanced NLP in The Applied AI Podcast. We dive into healthcare, finance, legal, life sciences, and more with expert interviews, practical case studies, and insights on open-source tools and frameworks. Discover how organizations deploy AI at scale, navigate ethical and technical challenges, and unlock transformative business value. Open and impactful discussions for AI professionals and enthusiasts.

Stay up to date on current trends in healthcare's digital transformation. Featuring C-suite executives from the healthcare and technology sectors, podcast hosts Rohit Mahajan and Ritu M. Uberoy discuss how they are driving digital health innovation and leveraging emerging technologies to create the healthcare experiences of the future.

About the hosts:

Rohit Mahajan, Managing Partner and CEO, Damo and BigRio: Rohit is an entrepreneur and a leader in the information technology and software industry. His focus lies in the field of artificial intelligence and digital transformation for healthcare clients. His recently published full length book,  Quantum Care, A Deep Dive into AI for Health Delivery and Research has been trending #1 in several categories on Amazon. Rohit is a Wharton School Fellow and a graduate from the Harvard Business School. You can follow and connect with him on https://www.linkedin.com/in/rmahaj/

Ritu M. Uberoy, Managing Partner at Damo and BigRio has over twenty-five years of experience in the software and information technology industry in the United States and in India. She established Saviance Technologies in India and has been involved in the delivery of several successful software projects and products to clients in various industry segments.
You can follow and connect with her on https://www.linkedin.com/in/ritu-m-uberoy/

To receive alerts on new episodes, please subscribe to The Healthcare Digital Transformation Leader newsletter. Link is provided below.

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

The dopest podcast on this side of the milky way!

New tracks tagged #HealthcareAI